Recreational Use of Mephedrone (4-Methylmethcathinone, 4-MMC) with Associated Sympathomimetic Toxicity

Journal of Medical Toxicology

Volumn 6, Issue 3, 2010, Pages 327-330

  Wood, David M ^a,e   Davies, Susannah ^b   Puchnarewicz, Malgorzata ^b   Button, Jenny ^b   Archer, Roland ^c   Ovaska, Hanna ^d   Ramsey, John ^b   Lee, Terry ^b   Holt, David W ^b   Dargan, Paul I ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c KINGSTON UNIVERSITY   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e GUY S HOSPITAL   (United Kingdom)

Author keywords

4 Methylmethcathinone; Khat; Mephedrone; Recreational drugs; Toxicological screening

Indexed keywords

LORAZEPAM; MEPHEDRONE; METHCATHINONE; RECREATIONAL DRUG; UNCLASSIFIED DRUG; 4' METHYLMETHCATHINONE; ADRENERGIC RECEPTOR STIMULATING AGENT; METHAMPHETAMINE; STREET DRUG;

ADRENERGIC STIMULATION; ADULT; ANXIETY DISORDER; ARTICLE; BLOOD ANALYSIS; BLURRED VISION; CASE REPORT; CHEST TIGHTNESS; CLINICAL FEATURE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MISUSE; ELECTROCARDIOGRAM; EMERGENCY CARE; HEART PALPITATION; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; MYDRIASIS; NEUROTOXICITY; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RESTLESSNESS; SINGLE DRUG DOSE; SWEATING; TACHYCARDIA; TANDEM MASS SPECTROMETRY; TOXICITY TESTING; URINALYSIS; ANALOGS AND DERIVATIVES; TOXICITY;

ADULT; HUMANS; MALE; METHAMPHETAMINE; STREET DRUGS; SYMPATHOMIMETICS;

EID: 77956229460     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-010-0018-5     Document Type: Article

References (26)

1. Patel NB (2000) Mechanism of action of cathinone: the active ingredient of khat (Catha edulis). East Afr Med J 77: 329-332.
2. Feyissa AM, Kelly JP (2008) A review of the neuropharmacological properties of khat. Prog Neuropsychopharmacol Biol Psychiatry 32: 1147-1166.
3. Pennings EJ, Opperhuizen A, van Amsterdam JG (2008) Risk assessment of khat use in the Netherlands: a review based on adverse health effects, prevalence, criminal involvement and public order. Regul Toxicol Pharmacol 52: 199-207.
4. Nencini P, Ahmed AM (1989) Khat consumption: a pharmacological review. Drug Alcohol Depend 23: 19-29.
5. Kalix P, Braenden O (1985) Pharmacological aspects of the chewing of khat leaves. Pharmacol Rev 37: 149-164.
6. Kalix P, Khan I (1984) Khat: an amphetamine-like plant material. Bull World Health Organ 62: 681-686.
7. Giannini AJ, Burge H, Shaheen JM, Price WA (1986) Khat: another drug of abuse? J Psychoactive Drugs 18: 155-158.
8. The Local (2008) Teenager dies of 'net drug' overdose. Sweden's news in English. http://www. thelocal. se/16366/20081215/. Accessed 10 Aug 2009, Updated 15 Dec 2008.
9. Erowid Experience Vaults (2008) Testing a new friend. http://www. erowid. org/experiences/exp. php?ID=69642. Accessed 10 Aug 2009, Updated 9 Apr 2008.
10. Erowid Experience Vaults (2009) Stimulation without euphoria. http://www. erowid. org/experiences/exp. php?ID=77309. Accessed 10 Aug 2009, Updated 27 May 2009.
11. Erowid Experience Vaults (2008) Stimulant heaven and the otherworldly euphoria. http://www. erowid. org/experiences/exp. php?ID=72394. Accessed 10 Aug 2009, Updated 18 Dec 2008.
12. Erowid Experience Vaults (2008) Far too much. http://www. erowid. org/experiences/exp. php?ID=75806. Accessed 10 Aug 2009, Updated 22 Dec 2008.
13. Bentur Y, Bloom-Krasik A, Raikhlin-Eisenkraft B (2008) Illicit cathinone ("Hagigat") poisoning. Clin Toxicol (Phila) 46: 206-210.
14. Belhadj-Tahar H, Sadeg N (2005) Methcathinone: a new postindustrial drug. Forensic Sci Int 153: 99-101.
15. Emerson TS, Cisek JE (1993) Methcathinone: a Russian designer amphetamine infiltrates the rural Midwest. Ann Emerg Med 22: 1897-1903.
16. Sanotsky Y, Lesyk R, Fedoryshyn L, Komnatska I, Matviyenko Y, Fahn S (2007) Manganic encephalopathy due to "Ephedrone" abuse. Mov Disord 22: 1337-1343.
17. Stepens A, Logina I, Liguts V, Aldins P, Eksteina I, Platkājis A, Mārtinsone I, Tērauds E, Rozentāle B, Donaghy M (2008) A Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 358: 1009-1017.
18. Levin OS (2005) "Ephedron" encephalopathy. Zh Nevrol Psikhiatr Im S S Korsakova 105: 12-20.
19. Sikk K, Taba P, Haldre S, Bergquist J, Nyholm D, Zjablov G, Asser T, Aquilonius SM (2007) Irreversible motor impairment in young addicts-ephedrone, manganism or both? Acta Neurol Scand 115: 385-389.
20. de Bie RM, Gladstone RM, Strafella AP, Ko JH, Lang AE (2007) Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. Arch Neurol 64: 886-889.
21. Selikhova M, Fedoryshyn L, Matviyenko Y, Komnatska I, Kyrylchuk M, Krolicki L, Friedman A, Taylor A, Jäger HR, Lees A, Sanotsky Y (2008) Parkinsonism and dystonia caused by the illicit use of ephedrone-a longitudinal study. Mov Disord 23: 2224-2231.
22. Varlibas F, Delipoyraz I, Yuksel G, Filiz G, Tireli H, Gecim NO (2009) Neurotoxicity following chronic intravenous use of Russian cocktail. Clin Toxicol (Phila) 47: 157-160.
23. Lidder S, Dargan PI, Sexton M, Button J, Ramsey J, Holt DW, Wood DM (2008) Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol (D2PM)). J Med Toxicol 4: 167-169.
24. Dargan PI, Button J, Hawkins L, Archer J, Ovaska H, Lidder S, Ramsey J, Holt DW, Wood DM (2008) Detection of the pharmaceutical agent 'Glaucine' as a recreational drug. Eur J Clin Pharmacol 64: 553-554.
25. Ovaska H, Viljoen A, Puchnarewicz M, Button J, Ramsey J, Holt DW, Dargan PI, Wood DM (2008) First case report of recreational use of 2, 5-dimethoxy-4-chloroamphetamine (DOC) confirmed by toxicological screening. Eur J Emerg Med 15: 354-356.
26. Wood DM, Button J, Lidder S, Ramsey J, Holt DW, Dargan PI (2008) Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP). J Med Toxicol 4: 254-257.